Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Voss

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Ear and Hearing|August 1, 2013
Consensus statement: Eriksholm workshop on wideband absorbance measures of the middle earM Patrick Feeney, Lisa L Hunter, Joseph Kei, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonistsMatthew E Voss, Percy H Carter, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2009
Synthesis and SAR of vinca alkaloid analoguesMatthew E Voss, Jeffery M Ralph, Dejian Xie, et al.
Gene Therapy|April 10, 2026
Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoidsMary Tenuta, Morgan Bravo, Alex Olson, et al.
Cell Reports|February 2, 2018
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal ModelJames E Voss, Raiees Andrabi, Laura E McCoy, et al.
Nature Biotechnology|June 10, 2022
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in miceAlessio D Nahmad, Cicera R Lazzarotto, Natalie Zelikson, et al.
Science Advances|June 18, 2020
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersiteBartek Nogal, Laura E McCoy, Marit J van Gils, et al.
Cell Reports|October 6, 2017
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal ModelJames E Voss, Raiees Andrabi, Laura E McCoy, et al.
Elife|January 17, 2019
Reprogramming the antigen specificity of B cells using genome-editing technologiesJames E Voss, Alicia Gonzalez-Martin, Raiees Andrabi, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Ear and Hearing|August 1, 2013
Consensus statement: Eriksholm workshop on wideband absorbance measures of the middle earM Patrick Feeney, Lisa L Hunter, Joseph Kei, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonistsMatthew E Voss, Percy H Carter, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|January 17, 2009
Synthesis and SAR of vinca alkaloid analoguesMatthew E Voss, Jeffery M Ralph, Dejian Xie, et al.
Gene Therapy|April 10, 2026
Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoidsMary Tenuta, Morgan Bravo, Alex Olson, et al.
Cell Reports|February 2, 2018
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal ModelJames E Voss, Raiees Andrabi, Laura E McCoy, et al.
Nature Biotechnology|June 10, 2022
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in miceAlessio D Nahmad, Cicera R Lazzarotto, Natalie Zelikson, et al.
Science Advances|June 18, 2020
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersiteBartek Nogal, Laura E McCoy, Marit J van Gils, et al.
Cell Reports|October 6, 2017
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal ModelJames E Voss, Raiees Andrabi, Laura E McCoy, et al.
Elife|January 17, 2019
Reprogramming the antigen specificity of B cells using genome-editing technologiesJames E Voss, Alicia Gonzalez-Martin, Raiees Andrabi, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Pageof 20